Dr Jon Golding

Professional biography

My lab works mainly on improving the effectiveness of the anti-cancer treatments photodynamic therapy (PDT) and radiotherapy. A full list of my research publications can be found at PubMed or Researchgate

A two-year clinical trial of our new combination PDT, in collaboration with the University of Cambridge, began in October 2013. On the basis of the excellent trial results, this has been adopted as a standard treatment option by Cambridge Veterinary School. 

PI. Clinical trial of combination photodynamic therapy for equine sarcoids . European Society for Veterinary Dermatology (2013-2015). €20k

PI. Mechanisms of nanoparticle toxicity in normal and tumour cells. Industrial funding (2015-2018). £68k

Co-I. Targeting radiotherapy with DNA binding metal complexes and their attachment to gold nanoparticles. Royal Society of Chemistry (2015). £5k

Co-I. EU Framework 7 grant PEOPLE-2013-ITN ARGENT- Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies http://itn-argent.eu (2014-2017). £3.65M

Patent: Nanoparticles and their uses in medicine. GB1423049.4 (23/12/2014)

YouTube

Northampton Hospital

Northampton Chronicle

Together with colleagues at Milton Keynes University Hospital, we are planning to recruit breast cancer patients for a surgical pilot study of fluorescence-guided surgery in late 2018. 

I am looking to partner with clinicians and veterinary surgeons for a series of further clinical trials. Please contact Jon for further details.

My main teaching interest is in developing global online life sciences education (e.g SK320 'infectious disease and public health').

SK320 module chair

S390 module chair (and SXL390 strand chair)

Module author for S317 and S110

I am setting up a surgical pilot study of fluorescence-guided breast cancer surgery with surgeons at Milton Keynes University Hospital. We hope to be enrolling patients in August 2018. More information to come soon...

I collaborate with:

• Clinicians at Milton Keynes University Hospital and Northampton Hospital.
• Veterinary surgeons at the University of Cambridge and Nottingham Trent University
• Pharmaceutical companies (Midatech Pharma, Glaxo Smith Kline).
• New University of Lisbon (RaBBiT program)
• ARGENT ITN http://itn-argent.eu

As chair of the Life and Biomolecular Sciences Management Group, I work to oversee PhD candidate training in OU Affiliated Research Centres (ARCs) around the world and to foster research relationships between ARCs.